Zhang R - Search Results

1

Comprehensive genomic profiling of neuroendocrine bladder cancer pinpoints molecular origin and potential therapeutics.

Shen P, Jing Y, Zhang R, Cai MC, Ma P, Chen H, Zhuang G. Shen P, et al. Among authors: zhang r. Oncogene. 2018 May;37(22):3039-3044. doi: 10.1038/s41388-018-0192-5. Epub 2018 Mar 14. Oncogene. 2018. PMID: 29535424

2

BCMab1-Ra, a novel immunotoxin that BCMab1 antibody coupled to Ricin A chain, can eliminate bladder tumor.

Li C, Yan R, Yang Z, Wang H, Zhang R, Chen H, Wang J. Li C, et al. Among authors: zhang r. Oncotarget. 2017 Jul 11;8(28):46704-46705. doi: 10.18632/oncotarget.13504. Oncotarget. 2017. PMID: 28578321 Free PMC article.

3

Prevalence and clonality of synchronous primary carcinomas in the bladder and prostate.

Jing Y, Zhang R, Ma P, Cai MC, Zhuang G, Chen H. Jing Y, et al. Among authors: zhang r. J Pathol. 2018 Jan;244(1):5-10. doi: 10.1002/path.4997. J Pathol. 2018. PMID: 29023722

4

A Genomic-clinicopathologic Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer.

Wu SX, Huang J, Liu ZW, Chen HG, Guo P, Cai QQ, Zheng JJ, Qin HD, Zheng ZS, Chen X, Zhang RY, Chen SL, Lin TX. Wu SX, et al. EBioMedicine. 2018 May;31:54-65. doi: 10.1016/j.ebiom.2018.03.034. Epub 2018 Mar 31. EBioMedicine. 2018. PMID: 29655996 Free PMC article. Clinical Trial.

5

Curcumin inhibits cell proliferation and motility via suppression of TROP2 in bladder cancer cells.

Zhang L, Yang G, Zhang R, Dong L, Chen H, Bo J, Xue W, Huang Y. Zhang L, et al. Among authors: zhang r. Int J Oncol. 2018 Aug;53(2):515-526. doi: 10.3892/ijo.2018.4423. Epub 2018 May 30. Int J Oncol. 2018. PMID: 29901071 Free PMC article.

6

Somatic FGFR3 Mutations Distinguish a Subgroup of Muscle-Invasive Bladder Cancers with Response to Neoadjuvant Chemotherapy.

Yang Z, Zhang R, Ge Y, Qin X, Kang X, Wang Y, Zhang X, Song C, Quan X, Wang H, Chen H, Li C. Yang Z, et al. Among authors: zhang r, zhang x. EBioMedicine. 2018 Sep;35:198-203. doi: 10.1016/j.ebiom.2018.06.011. Epub 2018 Jun 22. EBioMedicine. 2018. PMID: 29941343 Free PMC article.

7

Diffusion kurtosis imaging to assess correlations with clinicopathologic factors for bladder cancer: a comparison between the multi-b value method and the tensor method.

Wang F, Chen HG, Zhang RY, Jin D, Xu SS, Wu GY, Xu JR. Wang F, et al. Eur Radiol. 2019 Aug;29(8):4447-4455. doi: 10.1007/s00330-018-5977-y. Epub 2019 Jan 21. Eur Radiol. 2019. PMID: 30666451

8

Aberrantly glycosylated integrin α3β1 is a unique urinary biomarker for the diagnosis of bladder cancer.

Jin D, Zhang R, Chen H, Li C. Jin D, et al. Among authors: zhang r. Aging (Albany NY). 2020 Jun 13;12(11):10844-10862. doi: 10.18632/aging.103297. Epub 2020 Jun 13. Aging (Albany NY). 2020. PMID: 32534450 Free PMC article.

9

Co-Expression of Stem Cell and Epithelial Mesenchymal Transition Markers in Circulating Tumor Cells of Bladder Cancer Patients.

Zhang R, Xia J, Wang Y, Cao M, Jin D, Xue W, Huang Y, Chen H. Zhang R, et al. Onco Targets Ther. 2020 Oct 22;13:10739-10748. doi: 10.2147/OTT.S259240. eCollection 2020. Onco Targets Ther. 2020. PMID: 33122913 Free PMC article.

10

FTO modifies the m6A level of MALAT and promotes bladder cancer progression.

Tao L, Mu X, Chen H, Jin D, Zhang R, Zhao Y, Fan J, Cao M, Zhou Z. Tao L, et al. Among authors: zhang r. Clin Transl Med. 2021 Feb;11(2):e310. doi: 10.1002/ctm2.310. Clin Transl Med. 2021. PMID: 33634966 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37,475 results

Search Page

Filters